Attune Pharmaceuticals Private
Attune Pharmaceuticals is a private biotechnology company focused on discovering and developing novel oral once-daily small-molecule therapeutics for the treatment of rare diseases.
Founded Date:
2018
Last Funding Date:
2019
Industry:
PharmTech
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Total Funding:
23000000
Headquarters:
New York, New York, United States
Investor Type:
Early Stage Venture
Investors Number:
6
Employee Number:
1-10